Polaris Group (TPE:6550)

Taiwan · Delayed Price · Currency is TWD

13.70

-0.60 (-4.20%)

Nov 6, 2026, 1:30 PM CST

Market Cap	6.37B -74.9%
Revenue (ttm)	67.95M +6.1%
Net Income	-3.77B
EPS	-8.86
Shares Out	464.85M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	618,385
Open	13.10
Previous Close	14.30
Day's Range	13.10 - 13.95
52-Week Range	13.10 - 69.20
Beta	0.70
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 12, 2026

About Polaris Group

Polaris Group, together with its subsidiaries, offers biotechnology, pharmaceutical testing, and contract development and manufacturing services. The company engages in the research, development, manufacture and sale of new drugs. It also offers healthcare consulting, staffing, and MDS solutions. The company was incorporated in 2006 and is based in Grand Cayman, Cayman Islands. [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2006

Country Cayman Islands

Stock Exchange Taiwan Stock Exchange

Ticker Symbol 6550

Full Company Profile

Financial Performance

In 2025, Polaris Group's revenue was 40.60 million, a decrease of -62.05% compared to the previous year's 107.00 million. Losses were -3.93 billion, 56.9% more than in 2024.

Financial Statements